| Literature DB >> 24486134 |
Yao Ma1, Brian R Lahue2, Gerald W Shipps2, Jeseca Brookes2, Yaolin Wang2.
Abstract
Novel small molecule HDM2 inhibitor, substituted piperidine, was identified. Initial SAR study indicated potential for several position optimizations. Additional potency enhancement was achieved by introducing a sidechain off the aromatic ring. DMPK study of one of the active compounds has shown a moderate oral PK and reasonable bioavailability.Entities:
Keywords: Cancer; HDM2; MDM2; Oncology; Small molecule inhibitor; Substituted piperidine; p53
Mesh:
Substances:
Year: 2014 PMID: 24486134 DOI: 10.1016/j.bmcl.2014.01.026
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823